Denna sida på svenska
Loading profile information...

About me

I am Haris Charalampos Antypas and I am a Postdoctoral Research Fellow in Richter-Dahlfors group at the Swedish Medical Nanoscience Center.

I am an innovation-driven microbiologist with experience in assay development for research and diagnostics. During my doctoral studies I learned how to work seamlessly across different disciplines and identify opportunities in emerging technologies in order to improve healthcare. By combining microbiology with microfabricated devices and optical tools I have worked on the following projects:

1. A rapid antibiotic susceptibility testing assay using a miniaturized nanotiter plate and algorithm-assisted analysis
2. Real-time studies of host-pathogen interactions in a microfluidic model of the renal proximal tubule
3. FACS-based selection of single bacterial mutants and subsequent high-resolution phenotypic screening on a miniaturized device
4. A rapid diagnostic assay for biofilm-related infections using luminescence conjugated polymers


Academic honours, awards and prizes

Recipient of the €50k Gold Award of the PhD Transition Fellowship Programme from EIT Health to accelerate the development of a diagnostic assay for biofilm-related infections

Nominated and sponsored by Karolinska Institutet to attend the Global Young Scientists Summit@one-north, 17-22 January 2016, Singapore

2nd poster prize award in Karolinska Institutet Infection Biology Retreat, 24-25 August 2015, Stockholm, Sweden

ESCMID attendance grant for the Postgraduate Technical Workshop “3rd Workshop on Antimicrobial Susceptibility Testing and Surveillance”, September 2014, Linz, Austria


A universal platform for selection and high-resolution phenotypic screening of bacterial mutants using the nanowell slide
Antypas H, Veses-garcia M, Weibull E, Andersson-svahn H, Richter-dahlfors A
Lab on a chip 2018;18(12):1767-1777

Rapid Phenotypic Antibiotic Susceptibility Testing of Uropathogens Using Optical Signal Analysis on the Nanowell Slide
Veses-garcia M, Antypas H, Löffler S, Brauner A, Andersson-svahn H, Richter-dahlfors A
Frontiers in microbiology 2018;9():1530-

Integrated Pathophysiology of Pyelonephritis
Choong Fx, Antypas H, Richter-dahlfors A
Microbiology spectrum 2015;3(5):-

Bacterial nanoscale cultures for phenotypic multiplexed antibiotic susceptibility testing
Weibull E, Antypas H, Kjäll P, Brauner A, Andersson-svahn H, Richter-dahlfors A
Journal of clinical microbiology 2014;52(9):3310-7

Reducing background cytokine expression in epithelial cells without serum starvation
Antypas H, Libberton B, Melican K
MethodsX 2014;1():251-3


Biomimetic tools enabling in vitro studies of host-pathogen interactions under physiologically relevant conditions. Antypas H, Simonet T, Richter-Dahlfors A. 32nd Meeting of Nordic Society of Clinical Microbiology and Infectious Diseases (NSCMID) – Infection and Antibiotics, 3-6 September 2015, Väven Umeå, Sweden

Development of a high-throughput single-bacterium screening platform. Antypas H , Veses Garcia M, Weibull E, Andersson-Svahn H, Richter-Dahlfors A. 6th International Conference on Analysis of Microbial Cells at the Single Cell Level. 2015, Retz, Austria

Nanomedicine for clinical diagnostics for antibiotic susceptibility. Antypas H, Weibull E, Kjäll P, Brauner A, Andersson-Svahn H, Richter-Dahlfors A. Karolinska Institutet Infection Biology Retreat 2014, Stockholm, Sweden

The synergistic role of Type 1 and P fimbriae of Uropathogenic Escherichia coli in pyelonephritis. Antypas H, Melican K, Sandoval RM, Kader A, Josefsson L, Tanner GA, Molitoris BA, Richter-Dahlfors A. 9th Annual EIMID Meeting, 2012, Dunblane, UK 



The Petri dish reinvented: Bringing bacterial mutant screens into the 21st century. Link to publication: 




A diagnostic method for biofilm-related urinary tract infections

Link to publication: